J&J's Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules 'Not An Innovative Drug' - Yahoo Finance

Submitted by Anonymous (not verified) on Mon, 08/09/2021 - 18:19

J&J's Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules 'Not An Innovative Drug'  Yahoo Finance